Literature DB >> 23601670

Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.

S Hamza1, V Dancourt, C Lejeune, J M Bidan, C Lepage, J Faivre.   

Abstract

BACKGROUND: Quantitative immunochemical faecal occult blood tests have become the recommended tests for colorectal cancer screening. The aim of this study was to complete our knowledge on the performance of one of the quantitative immunochemical tests available, FOB-Gold, and to propose a possible strategy for an organised screening programme. PATIENTS AND METHODS: Within the French organised screening programme, 23,231 average-risk individuals, aged 50-74 performed both a 3-day Hemoccult test and a 1-day FOB-Gold test. Performances of the immunochemical test were evaluated at different cut-off levels.
RESULTS: The positivity rate for the Hemoccult was 2.1% and for the FOB-Gold varied between 4.6% (cut-off value of 100 ng/mL, the lowest studied cut-off) and 2.1% (cut-off value of 352 ng/mL). The number of colonoscopies decreased with increasing cut-off values by 21.5% (150 ng/mL), 35.4% (200 ng/mL) and 53.3% (352 ng/mL). The corresponding miss rate for CRC was respectively 6.4%, 11.1% and 22.2%, and for advanced adenoma respectively 16.3%, 29.2% and 43.6%. Compared with the reference cut-off for the FOB-Gold (100 ng/mL) the miss rate for Hemoccult was 53% for CRC and 77% for advanced adenoma.
CONCLUSION: The study suggests that in countries with colonoscopy facilities compatible with a screening test positivity rate of up to 5%, use of a 1-day test with a cut-off value between 100 and 150 ng/mL could be the recommended strategy. Further increasing the cut-off value up to the same positivity rate as Hemoccult could be used in areas with limited access to colonoscopy.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Immunochemical faecal occult blood tests; Screening

Mesh:

Year:  2013        PMID: 23601670     DOI: 10.1016/j.ejca.2013.03.023

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Guideline sheets on the side effects of anticancer drugs are useful for general practitioners.

Authors:  Marie-Eve Rouge-Bugat; Donia Lassoued; Joy Bacrie; Nathalie Boussier; Jean-Pierre Delord; Stéphane Oustric; Eric Bauvin; Maryse Lapeyre-Mestre; François Bertucci; Pascale Grosclaude
Journal:  Support Care Cancer       Date:  2015-03-27       Impact factor: 3.603

2.  A fluorescent microsphere-based immunochromatographic strip is effective for quantitative fecal blood testing in colorectal cancer screening.

Authors:  Qingbing Wang; Jiwu Wang; Zeru Xiao; Zhiling Shen; Yanjun Wang; Yong Zhang; Tianyuan Pan; Jianan Xiao; Xiyuan Sun
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 3.940

3.  The Optimal Cut-Off Level of The Fecal Immunochemical Test For Colorectal Cancer Screening in a Country with Limited Colonoscopy Resources: A Multi-Center Study from Thailand

Authors:  Satimai Aniwan; Thawee Ratanachu Ek; Supot Pongprasobchai; Julajak Limsrivilai; Ong Ard Praisontarangkul; Pises Pisespongsa; Pisaln Mairiang; Apichat Sangchan; Jaksin Sottisuporn; Naruemon Wisedopas; Pinit Kullavanijaya; Rungsun Rerknimitr
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

Review 4.  Colorectal cancer population screening programs worldwide in 2016: An update.

Authors:  Mercedes Navarro; Andrea Nicolas; Angel Ferrandez; Angel Lanas
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

Review 5.  Stool-Based Tests for Colorectal Cancer Screening: Performance Benchmarks Lead to High Expected Efficacy.

Authors:  Derek W Ebner; John B Kisiel
Journal:  Curr Gastroenterol Rep       Date:  2020-06-03

6.  Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial.

Authors:  Hye Young Shin; Mina Suh; Hyung Won Baik; Kui Son Choi; Boyoung Park; Jae Kwan Jun; Sang-Hyun Hwang; Byung Chang Kim; Chan Wha Lee; Jae Hwan Oh; You Kyoung Lee; Dong Soo Han; Do-Hoon Lee
Journal:  Gut Liver       Date:  2016-11-15       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.